Chromatography demand surged with the sudden outburst of the pandemic for vaccine development and production. The market kept on growing as the vaccine was developed and demand for the vaccine surged during 2021 and 2022. In the year 2023, the market witnessed a downturn of double digits due to pandemic-related extraordinary business and inventory buildup by customers in previous years.
However, the biopharma chromatography systems market is likely to grow at a healthy of 8.8% in the long run to reach US$ 5.7 Billion in 2030. Major factors such as the growing biopharma industry coupled with ongoing advancements and innovations in the field of chromatography system technology and increasing R&D in drug development are expected to drive the market during the forecast period. In addition to that, the shift from traditional chromatography systems to single-use systems is likely to give impetus to the demand for chromatography systems.
Based on the media type, the market is segmented into liquid and gas. Liquid chromatography is expected to remain dominant as well as the faster-growing media type in the market during the forecast period. The growth of liquid chromatography can be attributed to its ability to offer superior performance and separation efficiency, which has led to an increase in the demand for this technology. Additionally, the compatibility of liquid chromatography with a wide range of biomolecules has made it an essential tool in biopharmaceutical research and development. Furthermore, the ease of integration of liquid chromatography with other analytical techniques has made it a popular choice among researchers.
Based on the end-use industry type, the market is segmented into biopharmaceutical companies, life sciences & academic research, and CMO. CMO is expected to be the fastest-growing end-use industry type in the market during the forecast period. CMOs play a crucial role in the growth of the biopharma chromatography systems market due to outsourcing trends, flexibility needs, and the diverse product landscape.
In terms of regions, North America is expected to remain the largest market for biopharma chromatography systems during the forecast period. This region has huge investments in the healthcare sector and is home to many major players, such as Thermo Fisher Scientific Inc., Waters Corporation, and Agilent Technologies, which make the region a growth engine of the biopharmaceutical industry. In addition to that, the USA is a preeminent nation in biopharmaceutical innovation worldwide and is expected to remain the largest market by 2030.
Asia-Pacific is anticipated to be the fastest-growing region during the forecast period driven by emerging economies, such as China and India. Expanding biopharma sector, establishing biotech clusters, and focusing on developing novel biologics and biosimilars will fuel the Chinese market whereas India is poised to emerge as the fastest-growing hub for biologics and biosimilars.
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with the analyst's internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. The analyst conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
However, the biopharma chromatography systems market is likely to grow at a healthy of 8.8% in the long run to reach US$ 5.7 Billion in 2030. Major factors such as the growing biopharma industry coupled with ongoing advancements and innovations in the field of chromatography system technology and increasing R&D in drug development are expected to drive the market during the forecast period. In addition to that, the shift from traditional chromatography systems to single-use systems is likely to give impetus to the demand for chromatography systems.
Recent Product Developments
- In October 2023, Trelleborg AB launched composite pre-packed columns for chromatography systems using reinforced polypropylene to replace the traditional unreinforced pp, stainless steel, and acrylic columns.
- In 2020, Cytiva Life Sciences successfully tested their disposable ready-to-process columns to be reused for up to 50 cycles without compromising the result.
Recent Market JVs and Acquisitions
A fair number of strategic alliances including M&As, JVs, etc. have been performed over the past few years:- In April 2023, Repligen Corporation, a global leader in single-use columns, announced the completion of its acquisition of Flex Biosys Inc., to provide total solutions for single-use chromatography systems.
- In February 2022, Sartorius AG, a global leader in single-use technology, acquired Novasep’s chromatography division, a leading provider of purification-based manufacturing solutions for life science molecules, to expand its market position in the chromatography market.
Based on the media type, the market is segmented into liquid and gas. Liquid chromatography is expected to remain dominant as well as the faster-growing media type in the market during the forecast period. The growth of liquid chromatography can be attributed to its ability to offer superior performance and separation efficiency, which has led to an increase in the demand for this technology. Additionally, the compatibility of liquid chromatography with a wide range of biomolecules has made it an essential tool in biopharmaceutical research and development. Furthermore, the ease of integration of liquid chromatography with other analytical techniques has made it a popular choice among researchers.
Based on the end-use industry type, the market is segmented into biopharmaceutical companies, life sciences & academic research, and CMO. CMO is expected to be the fastest-growing end-use industry type in the market during the forecast period. CMOs play a crucial role in the growth of the biopharma chromatography systems market due to outsourcing trends, flexibility needs, and the diverse product landscape.
In terms of regions, North America is expected to remain the largest market for biopharma chromatography systems during the forecast period. This region has huge investments in the healthcare sector and is home to many major players, such as Thermo Fisher Scientific Inc., Waters Corporation, and Agilent Technologies, which make the region a growth engine of the biopharmaceutical industry. In addition to that, the USA is a preeminent nation in biopharmaceutical innovation worldwide and is expected to remain the largest market by 2030.
Asia-Pacific is anticipated to be the fastest-growing region during the forecast period driven by emerging economies, such as China and India. Expanding biopharma sector, establishing biotech clusters, and focusing on developing novel biologics and biosimilars will fuel the Chinese market whereas India is poised to emerge as the fastest-growing hub for biologics and biosimilars.
Key Players
The following are the key players in the biopharma chromatography systems market:- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Waters Corporation
- Agilent Technologies Inc.
- PerkinElmer, Inc.
- Danaher Corporation (Cytiva)
- Repligen Corporation
- Millipore Corporation (Merck)
- Sartorius AG
- Bio-Rad Laboratories, Inc.
Research Methodology
This strategic assessment report provides a comprehensive analysis that reflects today’s biopharma chromatography systems market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with the analyst's internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. The analyst conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:- Market structure: Overview, industry life cycle analysis, supply chain analysis.
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
- Market trend and forecast analysis.
- Market segment trend and forecast.
- Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
- COVID-19 impact and its recovery curve
- Attractive market segments and associated growth opportunities.
- Emerging trends.
- Strategic growth opportunities for the existing and new players.
- Key success factors.
The biopharma chromatography systems market is segmented into the following categories:
Biopharma Chromatography Systems Market, by System Type
- Single-Use Systems (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
- Multi-Use Systems (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
Biopharma Chromatography Systems Market, by Media Type
- Liquid (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
- Gas (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
Biopharma Chromatography Systems Market, by End-User Type
- Biopharmaceutical Companies (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
- Life Sciences & Academic Research (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
- CMO (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
Biopharma Chromatography Systems Market, by Region
- North America (Country Analysis: The USA, Canada, and Mexico)
- Europe (Country Analysis: Germany, France, The UK, and Rest of Europe)
- Asia-Pacific (Country Analysis: Japan, China, India, and Rest of Asia-Pacific)
- Rest of the World (Country Analysis: Brazil, Saudi Arabia, and Others)
Table of Contents
1. Executive Summary
2. Biopharma Chromatography Systems Market Environment Analysis
3. Biopharma Chromatography Systems Market Assessment (2018-2030) (US$ Billion and Thousand Units)
4. Single-Use Biopharma Chromatography Systems Market Trend (2018-2023) and Forecast (2024-2030)
5. Multi-Use Biopharma Chromatography Systems Market Trend (2018-2023) and Forecast (2024-2030)
6. Competitive Analysis
7. Strategic Growth Opportunities
8. Company Profiles of Key Players (Alphabetically Arranged)
9. Appendix
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Millipore Corporation
- PerkinElmer, Inc.
- Repligen Corporation
- Sartorius AG
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Methodology
LOADING...
